Figure 3.

Changes in blood levels for BLyS and APRIL after six months of treatment in active LN patients. Dots and bars show blood levels for BLyS (A) and APRIL (B) in patients with active LN class III or IV at baseline and 180 days posttreatment. APRIL, a proliferation-inducing ligand; BlyS, B lymphocyte activation protein; LN, lupus nephritis.

Treamtrakanpon et al. Arthritis Research & Therapy 2012 14:R252   doi:10.1186/ar4095
Download authors' original image